Physicochemical Properties
Molecular Formula | C7H9FN3O2P |
Molecular Weight | 217.14 |
Exact Mass | 217.042 |
CAS # | 70788-28-2 |
PubChem CID | 51173 |
Appearance | White to off-white solid powder |
Density | 1.457g/cm3 |
Index of Refraction | 1.574 |
LogP | 2.372 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Heavy Atom Count | 14 |
Complexity | 260 |
Defined Atom Stereocenter Count | 0 |
SMILES | c1cc(ccc1C(=O)NP(=O)(N)N)F |
InChi Key | QWZFVMCWPLMLTL-UHFFFAOYSA-N |
InChi Code | InChI=1S/C7H9FN3O2P/c8-6-3-1-5(2-4-6)7(12)11-14(9,10)13/h1-4H,(H5,9,10,11,12,13) |
Chemical Name | N-diaminophosphoryl-4-fluorobenzamide |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
References | [1]. Millner OE Jr, et al. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones. J Urol. 1982 Feb;127(2):346-50. |
Additional Infomation | N-diaminophosphoryl-4-fluorobenzamide is an organohalogen compound and a carbonyl compound. |
Solubility Data
Solubility (In Vitro) | DMSO : 14.29 mg/mL (65.81 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.43 mg/mL (6.59 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 14.3 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.6053 mL | 23.0266 mL | 46.0532 mL | |
5 mM | 0.9211 mL | 4.6053 mL | 9.2106 mL | |
10 mM | 0.4605 mL | 2.3027 mL | 4.6053 mL |